Cargando…

ATAD2 predicts poor outcomes in patients with ovarian cancer and is a marker of proliferation

The oncogene ATPase family AAA domain-containing protein 2 (ATAD2) has been demonstrated to promote malignancy in a number of different types of tumor; however, its expression and role in ovarian cancer (OC) remain unknown. In the present study, it was demonstrated that ATAD2 acts as both a marker a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Qun, Liu, Heshu, Li, Lina, Dong, Xiaomei, Ru, Xiaoli, Fan, Xiana, Wen, Tao, Liu, Jian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2019
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6910177/ https://www.ncbi.nlm.nih.gov/pubmed/31746426 http://dx.doi.org/10.3892/ijo.2019.4913

Ejemplares similares

ATAD2 as a Poor Prognostic Marker for Hepatocellular Carcinoma after Curative Resection
por: Hwang, Hye Won, et al.
Publicado: (2015)

ATAD2 Overexpression Identifies Colorectal Cancer Patients with Poor Prognosis and Drives Proliferation of Cancer Cells
por: Luo, Yang, et al.
Publicado: (2015)

Tumor-Promoting ATAD2 and Its Preclinical Challenges
por: Liu, Haicheng, et al.
Publicado: (2022)

Overexpression of ATAD2 indicates Poor Prognosis in Oral Squamous Cell Carcinoma
por: Wang, Xiao-Long, et al.
Publicado: (2020)

miR-372 down-regulates the oncogene ATAD2 to influence hepatocellular carcinoma proliferation and metastasis
por: Wu, Gang, et al.
Publicado: (2014)

Blame ATAD5 for factory closures
por: Leslie, Mitch
Publicado: (2013)

ATAD2 is a driver and a therapeutic target in ovarian cancer that functions by upregulating CENPE
por: Guruvaiah, Praveen, et al.
Publicado: (2023)

ATAD2 controls chromatin-bound HIRA turnover
por: Wang, Tao, et al.
Publicado: (2021)

Fragment-Based Screening of the Bromodomain of ATAD2
por: Harner, Mary J., et al.
Publicado: (2014)

Prognostic value of ATAD3 gene cluster expression in hepatocellular carcinoma
por: Liu, Xiaoling, et al.
Publicado: (2019)

miR-302 Suppresses the Proliferation, Migration, and Invasion of Breast Cancer Cells by Downregulating ATAD2
por: Hwang, Yo Sep, et al.
Publicado: (2022)

Mitophagy promotes sorafenib resistance through hypoxia-inducible ATAD3A dependent Axis
por: Wu, Hong, et al.
Publicado: (2020)

CLEC3B is downregulated and inhibits proliferation in clear cell renal cell carcinoma
por: Liu, Jian, et al.
Publicado: (2018)

Overexpression of TRIM44 is an independent marker for predicting poor prognosis in epithelial ovarian cancer
por: Liu, Shuang, et al.
Publicado: (2018)

The AAA-ATPase Yta4/ATAD1 interacts with the mitochondrial divisome to inhibit mitochondrial fission
por: He, Jiajia, et al.
Publicado: (2023)

Overexpression of RIPK4 Predicts Poor Prognosis and Promotes Metastasis in Ovarian Cancer
por: Liu, Shaoqiu, et al.
Publicado: (2021)

Integrative Analysis of Deep Sequencing Data Identifies Estrogen Receptor Early Response Genes and Links ATAD3B to Poor Survival in Breast Cancer
por: Ovaska, Kristian, et al.
Publicado: (2013)

C. elegans ATAD-3 Is Essential for Mitochondrial Activity and Development
por: Hoffmann, Michael, et al.
Publicado: (2009)

Congenital immobility and stiffness related to biallelic ATAD1 variants
por: Bunod, Roxane, et al.
Publicado: (2020)

Coordination of Di-Acetylated Histone Ligands by the ATAD2 Bromodomain
por: Evans, Chiara M., et al.
Publicado: (2021)

Cyclin H predicts the poor prognosis and promotes the proliferation of ovarian cancer
por: Peng, Chen, et al.
Publicado: (2020)

Effect of chronic intermittent hypoxia-induced HIF-1α/ATAD2 expression on lung cancer stemness
por: Hao, Shengyu, et al.
Publicado: (2022)

Predisposition to Cancer Caused by Genetic and Functional Defects of Mammalian Atad5
por: Bell, Daphne W., et al.
Publicado: (2011)

Overexpression of FOXM1 predicts poor prognosis and promotes cancer cell proliferation, migration and invasion in epithelial ovarian cancer
por: Wen, Ning, et al.
Publicado: (2014)

Integrated Bioinformatics Analysis of the Clinical Value and Biological Function of ATAD2 in Hepatocellular Carcinoma
por: Meng, Xiangyu, et al.
Publicado: (2020)

Atad3 Function Is Essential for Early Post-Implantation Development in the Mouse
por: Goller, Tobias, et al.
Publicado: (2013)

Functional interpretation of ATAD3A variants in neuro-mitochondrial phenotypes
por: Yap, Zheng Yie, et al.
Publicado: (2021)

ATAD3A: A Key Regulator of Mitochondria-Associated Diseases
por: Chen, Liting, et al.
Publicado: (2023)

Targeting ATAD3A-PINK1-mitophagy axis overcomes chemoimmunotherapy resistance by redirecting PD-L1 to mitochondria
por: Xie, Xiao-Qing, et al.
Publicado: (2023)

Knockdown of ATAD2 Inhibits Proliferation and Tumorigenicity Through the Rb-E2F1 Pathway and Serves as a Novel Prognostic Indicator in Gastric Cancer
por: Zhou, Xuan, et al.
Publicado: (2020)

Copeptin: A potential marker for the prediction of poor ovarian reserve in the ınfertile women
por: Görkem, Ümit, et al.
Publicado: (2022)

Epiphycan Predicts Poor Outcomes and Promotes Metastasis in Ovarian Cancer
por: Deng, Lu, et al.
Publicado: (2021)

Atad2 is a generalist facilitator of chromatin dynamics in embryonic stem cells
por: Morozumi, Yuichi, et al.
Publicado: (2016)

Emerging Links between Control of Mitochondrial Protein ATAD3A and Cancer
por: Lang, Liwei, et al.
Publicado: (2020)

CRISPR/Cas9-induced gene conversion between ATAD3 paralogs
por: Yanovsky-Dagan, Shira, et al.
Publicado: (2022)

Baculovirus LEF-11 Hijack Host ATPase ATAD3A to Promote Virus Multiplication in Bombyx mori cells
por: Dong, Zhan-Qi, et al.
Publicado: (2017)

CircRNA circ-ATAD1 suppresses miR-618 maturation to participate in colorectal cancer
por: Cao, Li, et al.
Publicado: (2022)

ATPase family AAA domain-containing protein 2 (ATAD2): From an epigenetic modulator to cancer therapeutic target
por: Fu, Jiahui, et al.
Publicado: (2023)

Aspirin Exerts Its Antitumor Effect in Esophageal Squamous Cell Carcinoma by Downregulating the Expression of ATAD2 and KIF4A
por: Zhang, Man, et al.
Publicado: (2022)

Higher expression of calcineurin predicts poor prognosis in unique subtype of ovarian cancer
por: Xin, Bing, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_engibcb3n14g81j87srmcpupeg